IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 104 filers reported holding IDEAYA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,330,653 | +30.4% | 1,161,105 | +13.5% | 0.00% | +33.3% |
| Q2 2023 | $24,034,703 | +103.6% | 1,022,753 | +18.9% | 0.00% | +50.0% |
| Q1 2023 | $11,806,898 | +80531.7% | 859,934 | +6.7% | 0.00% | 0.0% |
| Q4 2022 | $14,643 | -99.8% | 805,901 | +28.6% | 0.00% | +100.0% |
| Q3 2022 | $9,352,000 | +9.5% | 626,855 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $8,544,000 | +24.2% | 619,168 | +0.7% | 0.00% | 0.0% |
| Q1 2022 | $6,877,000 | -48.7% | 614,610 | +8.3% | 0.00% | -50.0% |
| Q4 2021 | $13,415,000 | -0.8% | 567,510 | +6.9% | 0.00% | 0.0% |
| Q3 2021 | $13,529,000 | +67.0% | 530,767 | +37.5% | 0.00% | +100.0% |
| Q2 2021 | $8,099,000 | +23.9% | 385,888 | +38.8% | 0.00% | 0.0% |
| Q1 2021 | $6,535,000 | +111.5% | 278,093 | +26.0% | 0.00% | 0.0% |
| Q4 2020 | $3,090,000 | +45.9% | 220,769 | +30.9% | 0.00% | – |
| Q3 2020 | $2,118,000 | +30.5% | 168,639 | +47.6% | 0.00% | – |
| Q2 2020 | $1,623,000 | – | 114,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |